Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Ballentine Carter, M.D., Director of Adult Urology at the Brady Urological Institute, comments on expectant management of prostate cancer.

Ballentine Carter, M.D., Director of Adult Urology at the Brady Urological Institute, comments on expectant management of prostate cancer.

listen   Listen to podcast now

Program Notes:

Ballentine Carter

0:20   What expectant management is no
1:15   Active surveillance

2:20   Try to predict disease that was small and low grade
3:17   Criteria based on biopsy findings
4:26    Carefully entered into database
5:30    Now has over 500 men ever enrolled
6:17   Accepted today for low risk disease
7:13    PSA velocity looks interesting
8:13   EPCA2 looks like a marker
9:05   Greatest hope is a panel of biomarkers
10:01 End

Additional Johns Hopkins Podcasts

 

Sign Up for e-News

Subscribe to the JHM Update for the latest news from Johns Hopkins Medicine.

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer